Tian An Medicare Limited (stock code: 00383) disclosed in a Next Day Disclosure Return dated 11 November 2025 that the total number of issued shares, at 1,082,430,457, remained unchanged between 31 October 2025 and 11 November 2025.

According to the announcement, 75,000 shares were repurchased on 27 October 2025 and an additional 10,000 shares on 11 November 2025 at HKD 0.99 each. These repurchased shares await cancellation and are not reflected in the total issued share count as of 11 November 2025.

The company also reported purchasing 10,000 shares on 11 November 2025 at a total cost of HKD 9,900 (at HKD 0.99 per share), all of which are designated for cancellation. Under the current repurchase mandate approved on 19 May 2025, Tian An Medicare Limited is authorized to repurchase up to 108,315,045 shares, and 805,000 shares have been repurchased so far, representing approximately 0.0743% of the number of issued shares on the resolution date.

The issuer indicated there will be a 30-day moratorium on new share issuance or sale or transfer of any treasury shares through 11 December 2025, unless otherwise approved by the Stock Exchange. All repurchases and relevant procedures have been conducted in accordance with applicable rules and statutory requirements.